TYPMF yields 322.58% · JNJ yields 2.14%● Live data
📍 TYPMF pulled ahead of the other in Year 1
Combined, TYPMF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of TYPMF + JNJ for your $10,000?
Tyro Payments Limited provides payment solutions to merchants in Australia. The company operates through Payments and Banking segments. It offers electronic funds transfer at point of sale (EFTPOS) solutions, business loans, and banking solutions. The company also acquires credit, debit, and EFTPOS cards; and offers Medicare and private health fund claiming and rebating services. In addition, it provides complementary banking solutions, including merchant cash advance, transaction account, and a term-deposit account. Further, the company offers Tyro Go, a mobile payment card reader; Tyro Connect that integrates apps and services with POS system designed for cafes, restaurants, QSRs, pubs, clubs, and bars; and Medipass, a digital health payment platform that links practitioners, funders, and patients. It primarily serves health, hospitality, services, corporate, accommodation, and retail industries. The company was incorporated in 2003 and is based in Sydney, Australia.
Full TYPMF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.